Table 2.
Proportion of patients reporting self-perceived cancer-related cognitive impairment (CRCI).
| Cognitive impairment based on: | Pooled Cohorta (n = 242) | Pre-menopausala (n = 122) | Post-menopausala (n = 120) | Chi-square test, χ2 (p-value) |
|---|---|---|---|---|
| Total FACT-Cog Score | 71 (29.3) |
41 (33.6) (n = 122) |
30 (25.0) (n = 120) |
0.14 |
| Mental acuity | 71 (29.3) |
43 (35.2) (n = 122) |
28 (23.3) (n = 120) |
0.042 |
| Concentration | 63 (26.1) |
42 (35.0) (n = 122) |
24 (17.6) (n = 119) |
0.003 |
| Memory | 38 (15.8) |
23 (18.9) (n = 122) |
15 (12.6) (n = 119) |
0.18 |
| Verbal fluency | 44 (18.2) |
21 (17.2) (n = 122) |
23 (19.2) (n = 120) |
0.69 |
| Functional Interference | 45 (18.7) |
28 (22.9) (n = 122) |
19 (15.9) (n = 119) |
0.08 |
| Multitasking | 63 (26.2) |
35 (28.7) (n = 122) |
28 (23.7) (n = 118) |
0.38 |
aData are presented as frequency (%) of patients.